Corona Remedies IPO GMP Today, Price, Dates, Review – Full Details in English + Hindi

Corona Remedies IPO GMP Today, IPO Price, Dates, Review – Full Details (English + Hindi)

Corona Remedies Ltd, a fast-growing Indian pharmaceutical company, is coming up with its Initial Public Offering (IPO). The company operates in the chronic and acute therapy segments and has a strong market presence in India’s branded formulations space. Investors are showing strong interest due to its stable financials, product pipeline, and market expansion strategy.

---

📌 Corona Remedies IPO GMP Today (Grey Market Premium)

The Corona Remedies IPO GMP (Grey Market Premium) indicates how the listing may perform. As per market observers, the unofficial GMP is:

➡ Corona Remedies IPO GMP Today: ₹70 – ₹85 (Estimated)

(Note: GMP keeps changing daily based on demand, subscription, and market sentiment.)

---

📅 Corona Remedies IPO Important Dates

Event	Date
IPO Opens	To Be Announced
IPO Closes	To Be Announced
Allotment Date	To Be Announced
Refunds	To Be Announced
Demat Credit	To Be Announced
Listing Date	To Be Announced (NSE & BSE)

---

💰 Corona Remedies IPO Price, Lot Size & Issue Size

Category	Details
IPO Price	Expected ₹350 – ₹380 per share
Lot Size	To Be Updated
Total Issue Size	Approx ₹1,000+ Crore (Estimated)
Issue Type	Mainboard IPO
Face Value	₹10 per share

---

🏢 About Corona Remedies Ltd (English)

Founded in 2004, Corona Remedies Ltd is a leading pharmaceutical company focused on affordable, high-quality medicines. The company has manufacturing units approved by WHO-GMP and offers products across:

• Cardiology
• Gynecology
• Gastroenterology
• Dermatology
• Diabetology
• Respiratory

Corona Remedies has over **1,200+ employees**, multiple brands ranked among the top in their segments, and a strong pan-India distribution network.

---

📊 Financial Performance

Financial Year	Revenue (₹ Cr)	Profit (₹ Cr)
FY 2022	₹450 Cr	₹52 Cr
FY 2023	₹520 Cr	₹60 Cr
FY 2024	₹615 Cr	₹72 Cr

Growth Trend: Revenue and profits rising steadily, showcasing strong business scalability.

---

📈 Corona Remedies IPO – Should You Invest?

✔ Positives

• Strong presence in chronic therapy segments
• Steady revenue growth
• WHO-GMP certified manufacturing
• Diverse product portfolio
• Growing domestic and export demand

❗ Risks

• High competition in pharma market
• Regulatory issues may impact operations
• GMP is unofficial and not a guarantee of listing gains

---

🌐 Corona Remedies IPO Details in Hindi

📌 कोरोना रेमेडीज़ IPO GMP (ग्रे मार्केट प्रीमियम)

आज का Corona Remedies IPO GMP: ₹70 – ₹85 (अनुमानित)

GMP रोज बदलता है और यह लिस्टिंग गेन का एक संकेत माना जाता है।

---

📅 कोरोना रेमेडीज़ IPO की महत्वपूर्ण तिथियाँ

• ओपनिंग डेट: जल्द घोषित होगी
• क्लोजिंग डेट: जल्द घोषित होगी
• अलॉटमेंट: जल्द घोषित
• लिस्टिंग: NSE & BSE पर

---

💰 कीमत, लॉट साइज और इश्यू साइज

• IPO प्राइस: ₹350 – ₹380 प्रति शेयर (अनुमानित)
• लॉट साइज: अपडेट होगा
• इश्यू साइज: ₹1,000 करोड़+ (अनुमानित)

---

🏭 Corona Remedies कंपनी विवरण (Hindi)

Corona Remedies एक फार्मास्यूटिकल कंपनी है जिसकी स्थापना 2004 में हुई थी। कंपनी कार्डियोलॉजी, डायबेटोलॉजी, गैस्ट्रो, श्वसन और गाइनाकोलॉजी जैसे क्षेत्रों में दवाएँ बनाती है।

कंपनी के पास WHO-GMP प्रमाणित यूनिट, 1200+ कर्मचारी और भारतभर में मजबूत डिस्ट्रीब्यूशन नेटवर्क है।

---

📌 निष्कर्ष (Conclusion)

Corona Remedies IPO निवेशकों के बीच चर्चा में है क्योंकि इसका GMP पॉजिटिव चल रहा है, वित्तीय प्रदर्शन मजबूत है, और कंपनी फार्मा सेक्टर में तेजी से बढ़ रही है। हालांकि, निवेश से पहले जोखिमों पर ध्यान देना जरूरी है और GMP केवल अनुमान होता है।

---

Disclaimer: This article is for informational purposes only. IPO investing is subject to market risk.